Division 5.9.4 Diagnosis of poisoning (determination of active substance, metabolites), specific signs of poisoning, clinical testsF1
United Kingdom
A detailed description of the clinical signs and symptoms of poisoning, including the early signs and symptoms and full details of clinical tests useful for diagnostic purposes, where available, must be provided and include full details of the time courses involved relevant to the ingestion, dermal exposure or inhalation of varying amounts of the active substance.
Annotations
Textual amendments
- F1
Repealed (subject to transitional measures in Arts. 3, 4) by Commission Regulation (EU) No 283/2013 of 1 March 2013 setting out the data requirements for active substances, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market Text with EEA relevance.
Notes on Division 5.9
Textual amendments
- F2
Words in Annex Pt. A point 5.9 inserted (31.12.2020) by The Plant Protection Products (Miscellaneous Amendments) (EU Exit) Regulations 2019 (S.I. 2019/556), regs. 1(1), 16(5)(b)(vi); 2020 c. 1, Sch. 5 para. 1(1)